Izotropic Corporation | News
February 19, 2021
Izotropic Launches New Website and Corporate Presentation

February 9, 2021
Izotropic Unveils “izoview” Branding For Breast CT Platform In Development And Files Trademark Applications

February 3, 2021
Izotropic Announces Upgrade to OTCQB Venture Market

January 11, 2021
Izotropic Grants Restricted and Performance Share Units

January 7, 2021
3D CT Imaging Expert Joins Izotropic Advisory

January 5, 2021
Izotropic Positioned to Execute in 2021

December 31, 2020
Izotropic Technology Founder Appointed Editor-In-Chief Of Medical Physics Journal

December 15, 2020
Izotropic Reports High Degree of Confidence After Pre-Submission Meeting With FDA

December 9, 2020
Izotropic Corporation Announces Closing of Non-Brokered Private Placement

December 1, 2020
Izotropic Cancels Options and Updates Amount of Broker Warrant Issued

November 2, 2020
Izotropic Engages Investor Relations and Market Awareness Consultants

October 30, 2020
Izotropic Corporation Announces Closing of Second Tranche of Non-Brokered Private Placement

October 26, 2020
Izotropic Unaware of Any Material Change

October 20, 2020
Izotropic Corporation Announces Non-Brokered Private Placement

October 6, 2020
Izotropic Announces 2020 AGM Results

September 28, 2020
Izotropic Announces Meeting Date With FDA

September 15, 2020
Mr. Alexander Tokman Joins Izotropic as Strategic Advisor

August 31, 2020
Izotropic Engages Marketsmart Communications

August 28, 2020
Izotropic Appoints Jaclyn Thast as Corporate Secretary

August 18, 2020
Izotropic Files Pre-Submission Application With U.S. FDA

August 4, 2020
Izotropic Unaware of Any Material Change

July 10, 2020
Izotropic Corporation Announces Adoption of Long Term Incentive Plan

July 8, 2020
Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design

July 6, 2020
Izotropic Corporation Appoints Executive Vice President of Commercial Operations

June 4, 2020
Izotropic Engages Mr. James Berard for Investor Relation Services

June 1, 2020
Izotropic Corporation Announces Warrant Amendment

May 27, 2020
Izotropic Corporation Announces Issuance of Warrants Pursuant to January Warrant Incentive Program, Delayed Due to Covid-19

May 25, 2020
Izotropic Begins FDA Approval Process

May 20, 2020
FDA Consultant Joins Izotropic Advisory Board

May 13, 2020
Izotropic Engages Starfish Medical for Design and Development of Commercial Breast CT Model

May 7, 2020
Izotropic Announces Issuance of Patent to Use Breast CT for Robotic Guided Biopsy

April 22, 2020
Izotropic Announces Addition of George Burkett, M.Eng to Advisory Board

April 15, 2020
Izotropic Announces Issuance of Patent to Measure Breast Density With Breast CT Technology

February 27, 2020
Izotropic Provides Update on Globally Licensed Breast CT Technology

February 26, 2020
Izotropic Successfully Extends Exclusive Global License Agreement for Innovative Breast CT Technology Until 2027

February 19, 2020
Izotropic Receives Notice of Allowance for Measuring Breast Density From US Patent Office

February 13, 2020
Izotropic Corporation Announces Apppointment of Dr. John Mcgraw to Advisory Board

February 11, 2020
Izotropic Corporation Raises $1.23M From Warrant Exercise Program

February 5, 2020
Izotropic Corporation Receives Notice of Allowance From US Patent Office

January 28, 2020
Izotropic Corporation Announces Warrant Exercise Incentive Program

January 23, 2020
Izotropic Corporation Announces Cancellation and Issuance of Stock Options

January 8, 2020
What Could Google’s AI Capability Do with Real 3D Breast CT Images?